1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Warning Letters

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
  • Frequently requested records may be accessed on the Reading Room page.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Bharat Overseas Inc. Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)
Macau-Union Pharmaceutical Limited Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drugs/Misbranded
Revlon Group Holdings, LLC Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated
PLZ Corp Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated
Jose M. Carpio, M.D. Center for Drug Evaluation and Research (CDER) Clinical Investigator
Gopaldas Visram & Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated
Fagron BV Center for Drug Evaluation and Research (CDER) Compounding Pharmacy/Adulterated Drug Products
Umendra Life Sciences Private Limited Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated
Laboratorios Dr. Collado S.A. Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated
Shantou Qiwei Industry Co., LTD Center for Drug Evaluation and Research (CDER) CGMP/OTC Finished Pharmaceuticals/Adulterated

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.
Back to Top